5 S&P 500 Stocks On the Move

3. Moderna, Inc. (NASDAQ:MRNA)

Number of Hedge Fund Holders: 37

Return Over Past Month as of January 18: 14.8%

Moderna, Inc. (NASDAQ:MRNA) is a biotech firm based in Cambridge. Moderna, Inc. (NASDAQ:MRNA) shares have performed better than peers in the past month after the company released unaudited data detailing that it had increased the COVID-19 vaccine share in the US market to 48% in 2023, up from 37% in 2022. The firm also reiterated a product sales outlook of $4 billion in 2024, based mainly on product launches in the second half of the year.

At the end of the third quarter of 2023, 37 hedge funds in the database of Insider Monkey held stakes worth $1.5 billion in Moderna, Inc. (NASDAQ:MRNA), compared to 40 in the preceding quarter worth $1.9 billion.